In recent years, orexin (ORX) and melanin-concentrating hormone (MCH) have been
demonstrated to exert neuroprotective roles in cerebral ischemia. Hence, this study …

El presente artÃculo está centrado en desarrollar una exposición general, desde una
visión comprehensiva, de los tres principales niveles, necesarios a tomar en cuenta al …

Background: Pharmacological treatments for ischemic stroke remain limited to thrombolysis,
which is associated with increased risk of potentially fatal hemorrhage. Treatments with …

Introduction Stroke is one of the common causes of mortality, morbidity and years of life lost
worldwide. Baseline research on stroke epidemiology, prevention, acute and rehabilitative …

Ischemic preconditioning (IP) reduces brain damage after subsequent ischemic strokes by
activating endogenous protective mechanisms in rodents. Transient ischemic attack (TIA) …

Introducción: se mantiene el debate sobre qué tipos de intervenciones para la recuperación
del ictus ofrecen mejores resultados para el paciente. Objetivo: evaluar el efecto de una …

目的初步探讨促红细胞生成素产生肝细胞B2 (EphB2) 受体在大鼠大脑中动脉栓塞(MCAO)
后功能恢复不同阶段中的作用. 方法将64 只大鼠分为假手术组, MCAO 造模后2, 14 和28 d 共4 …

Ischemic stroke can happen from insufficiency of blood flow to the brain tissue due to the
presence of thrombus in the blood vessel which obstruct blood flow to the brain. If left …

Ischemic stroke leads to the activation of resident microglia and astrocytes in the brain
parenchyma. It was previously thought that immune activation after ischemia is wholly …

Ischemic stroke causes a significant amount of cell death, including pericytes. Chronic
perfused phase of ischemic stroke, the number of pericytes increases, and limited research …